Skip to content
Omnikalc

Radioiodine patient release calculator

Enter the administered activity of iodine-131, the retained fraction, the effective half-life, the distance, the occupancy factor and your release criteria to get the dose rate at that distance, the dose to a person nearby and the time to wait before release.

Updated on

Educational tool, not medical advice: this page does not diagnose and does not replace a doctor, nurse or pharmacist. It has not been reviewed by a healthcare professional. Editorial and medical policy

Your inputs
MBq

Value out of range

µSv·m²/(MBq·h)

Value out of range

days

Value out of range

m

Value out of range

Value out of range

µSv/h

Value out of range

mSv

Value out of range

Results

Dose rate at the chosen distance

28.9 µSv/h

Total dose to a person nearby (until complete decay)
0.75 mSv
Within the dose limit for the person nearby
Waiting time to reach the release threshold at 1 m
1.6 days
Dose rate at 1 m
28.9 µSv/h
Distance for the dose rate to fall below the threshold
1.20 m

The radioiodine patient release calculator gives the dose rate at a distance, the dose to a person nearby and the waiting time before a patient treated with iodine-131 can leave the hospital, from the retained activity, the effective half-life and the occupancy.

How the calculation works

  • Enter the retained activity and the effective half-life.
  • Enter the distance, the occupancy factor and your limits.
  • Read the dose rate, the dose and the waiting time.

Example

A patient retaining 555 MBq has a dose rate of 0.052 × 555 / 1² = 28.9 µSv/h at 1 m. With an effective half-life of 3 days and an occupancy of 0.25, a person nearby gets 28.86 × 72 / 0.693 × 0.25 = 0.75 mSv in total. The dose rate at 1 m falls below 20 µSv/h after 1.6 days.

Why it matters

The calculator helps nuclear medicine physicians, physicists, nurses and radiation protection officers who prepare release instructions, and students who learn how the dose to the public is estimated.

Good to know

This is a simplified model. It treats the patient as a point source in air, ignores the shielding by the body, which lowers the measured dose rate, and uses one effective half-life, whereas the retention often follows two components. The occupancy factor depends on the situation, and instructions to a patient include sleeping apart, avoiding close contact with children and pregnant women, hygiene measures and travel limits for several days. The release criteria are set by national rules, and in some cases the patient is hospitalized in a shielded room until the activity falls below the limit. A measured dose rate with a calibrated instrument at the time of release is the best basis for the decision. This page is educational only.

The radioiodine activity calculator plans the treatment, the waste decay calculator treats storage, the inverse square law calculator shows the distance effect and the effective half-life calculator combines physical and biological clearance.

Frequently asked questions

How is the dose rate calculated?

The point source model gives Ḋ = Γ A / d², where Γ is the air kerma rate constant of iodine-131 (about 0.052 µGy·m²/(MBq·h)), A the retained activity and d the distance. The inverse square law explains why a few extra tens of centimeters reduce the dose a lot.

How is the total dose to a family member estimated?

The dose is the initial dose rate times the mean life of the activity in the body (Teff × 24 / ln 2, in hours) times the occupancy factor. Occupancy factors of 0.25 for a person at 1 m and lower for a more distant person are common in guidance.

Which criteria are used for release?

They depend on the country: a dose rate at 1 m (for example 20 or 30 µSv/h in several European countries), a retained activity, or a dose estimate below 1 mSv for the public and 5 mSv for a caregiver. Use your national rules and the instructions of the hospital.

Was this calculator helpful?

Thanks for your feedback!

Results are estimates provided for information purposes. They do not replace professional advice.